MALT lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{SR}}, {{AY}} | ||
==Overview== | ==Overview== | ||
Line 19: | Line 19: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 19:07, 18 December 2017
MALT lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
MALT lymphoma screening On the Web |
American Roentgen Ray Society Images of MALT lymphoma screening |
Risk calculators and risk factors for MALT lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2], Ahmed Younes M.B.B.CH [3]
Overview
There is insufficient evidence to recommend routine screening for MALT lymphoma.
Screening
There is insufficient evidence to recommend routine screening for MALT lymphoma.